Morbilidad por infecciones de partes blandas superficiales en el servicio de clínicas pediátricas de Manzanillo, Granma 2018 / Morbidity caused by soft tissue infections in the services of pediatric clinic in Manzanillo, Granma, 2018

RESUMEN Introducción: Las infecciones de la piel y partes blandas son frecuentes en los niños, con un amplio espectro de gravedad. Objetivo: Describir las características clínico-epidemiológicas de los pacientes con infecciones de partes blandas superficiales hospitalizados en el servicio de clínicas pediátricas del Hospital Pediátrico Docente "Hermanos Cordové". Método: Se realizó un estudio observacional, descriptivo y transversal en el servicio de clínicas pediátricas del Hospital Pediátrico Docente "Hermanos Cordové", de Manzanillo durante el 2018.Se estudiaron todos los pacientes egresados (n=298) con el diagnóstico confirmado de este tipo de infecciones. Se tomaron en cuenta las siguientes variables: localización anatómica, clasificación del tipo deinfección de piel y tejidos blandos, terapéutica utilizada y estadía hospitalaria. Resultados: Predominó el sexo masculino (57,7 %) y el grupo de edad de 10-14 años (34,9 %). Las infecciones en las extremidades estuvieron presentes en 113 pacientes (37,9 %). El impétigo fue la entidad clínica más frecuente (42,3 %), la cefazolina fue el antibiótico más utilizado (77,2 %). Se observó que la mayoría de los pacientes (293) solo permaneció hasta 7 días ingresados, con una evolución satisfactoria. Conclusiones: En el servicio de clínicas pediátricas del Hospital Pediátrico Docente "Hermanos Cordové", los pacientes con IPTB se caracterizan por ser sobre todo varones, más comúnmente con edad entre 10 y 14 años, las lesiones predominaron en las extremidades y la más común fue el impétigo. La cefazolina resultó eficaz para el tratamiento estas infecciones, lo que hizo posible que la estadía hospitalaria generalmente no excediera de siete días.

ABSTRACT Introduction: Infections in the skin and soft tissues are common health concerns in children, with a wide range of severity from patient to patient. Objective: To describe the clinical-epidemiological characteristics of the patients with soft tissue infections hospitalized in the Pediatric Teaching Hospital "Hermanos Cordové". Method: An observational, descriptive, cross-sectional study was carried out in the services of pediatric clinic in the Pediatric Teaching Hospital "Hermanos Cordové", in Manzanillo, Cuba, during the year 2018. All discharged patients who had a confirmed diagnosis of this type of infection were studied (n=298). The following variables were taken into account: anatomical location, classifications of the different types of skin and soft tissue infections, treatment used and hospitalization. Results: Male gender prevailed in the patients (57.7 %), and also the ages ranging between 10 to 14 years old (34.9 %). Infections located on the limbs were described in 113 patients (37.9 %). Impetigo was the most common diagnosis (42.3 %), and the most frequently used antibiotic was cefazolin (77.2 %). Most of the patients were hospitalized up to 7 days (293), with a satisfactory evolution of the disease. Conclusions: Patients with soft tissue infections in the services of pediatric clinic in the Pediatric Teaching Hospital "Hermanos Cordové" are mainly characterized for being male, especially from ages raging between 10 to 14 years old, with impetigo being the most common infection, mostly located on the limbs. Cefalozin resulted very effective for the treatment of these infections, making possible the hospitalization time to be lesser than a week.

Uso del Oleozon® en pacientes con giardiasis, impétigo contagioso y epidermofitosis de los pies / Use of Oleozon® in patients with giardiasis, contagious impetigo and epidermophytosis of feet

Se realizó una intervención terapéutica en 76 pacientes con giardiasis, impétigo contagioso y epidermofitosis de los pies, pertenecientes al consultorio No. 29 del Policlínico Docente "30 de Noviembre" de Santiago de Cuba, desde enero del 2013 hasta igual periodo del 2014, a fin de evaluar el uso del Oleozon® oral o tópico en el tratamiento de los afectados. En la casuística predominaron el sexo masculino (51,3 %), el grupo etario de 5-9 años (34,2 %) y los afectados con giardiasis (43,4 %). Se obtuvieron resultados favorables en 78,9 % de los pacientes, entre los cuales sobresalieron los que tenían giardiasis e impétigo.

A therapeutic intervention in 76 patients with giardiasis, contagious impetigo and epidermophytosis of feet, belonging to the doctor's office 29 of "30 de Noviembre" Teaching Polyclinic in Santiago de Cuba was carried out from January, 2013 to the same period of 2014, in order to evaluate the use of oral or topic Oleozon® in the treatment of those affected. Male sex (51.3%), the age group 5-9 years (34.2%) and those affected with giardiasis (43.4%) prevailed in the case material. Favorable results were obtained in 78.9% of the patients, among which there were those who had giardiasis and impetigo, with 31.6% each.

Impetigo - review

Impetigo is a common cutaneous infection that is especially prevalent in children. Historically, impetigo is caused by either group A β-hemolytic streptococci or Staphylococcus aureus. Currently, the most frequently isolated pathogen is S. aureus. This article discusses the microbiologic and virulence factors of group A β-hemolytic streptococci and Staphylococcus aureus, clinical characteristics, complications, as well as the approach to diagnosis and management of impetigo. Topical agents for impetigo therapy are reviewed.

Pustular psoriasis of pregnancy (Impetigo herpetiformis) - case report / Psoriase pustulosa da gestacao (Impetigo herpetiforme) - relato de caso

Impetigo herpetiformis is a rare dermatosis of pregnancy with typical onset during the last trimester of pregnancy and rapid resolution in the postpartum period. Clinically and histologically, it is consistent with pustular psoriasis. This similarity has led some authors to name the disease "the pustular psoriasis of pregnancy". We report the case of a patient who developed impetigo herpetiformis in two sucessive pregnancies.

Impetigo herpetiforme é uma dermatose gestacional rara que se inicia tipicamente durante o último trimestre e evolui com rápida resolução no período pós-parto. Clinica e histologicamente é consistente com psoríase pustulosa. Essa similaridade tem levado alguns autores a nomearem a doença como "psoríase pustulosa da gestação". Relatamos o caso de uma paciente que apresentou impetigo herpetiforme em duas gestações subsequentes.

Clinical assessment of azithromycin dihydrate in the treatment of pediatric impetigo / Avaliação clínica de azitromicina di-hidratada no tratamento de impetigo pediátrico

The primary objective of this double-blind, randomized, controlled clinical trial was to assess the use of azithromycin dihydrate in oral suspension form in the treatment of impetigo in children. The secondary objectives were to compare the efficacy and safety of two presentations of azithromycin dihydrate in the treatment of impetigo in children, on wound healing and on wound pruritus. After screening and obtaining informed consent of the parents or legal guardians, a total of 100 patients ranging in age from 2-8 years old and presenting impetigo were randomized to one of two groups for a 3-day treatment period using azithromycin dihydrate in oral suspension in single doses of 10mg/kg/day: Group A (manufactured by Merck S.A.), and Group B (manufactured by Pfizer). Patients returned to the study center at the end of the 3-day treatment (Visit 2) and 7 days after the Pretreatment visit (Visit 3) for efficacy assessments and safety monitoring. Pretreatment demographic data and impetigo characteristics (type, location, number of lesions, pruritus) were homogenous between treatment groups. At the end of the study, all patients in both groups presented either ?improvement? or ?cured? lesions, with the majority (72.9%) of the patients presenting ?cured? lesions. We observed a statistically significant decrease in pruritus severity at Visit 2 and Visit 3 in relation to pretreatment, with no significant between-group difference at either study visit. Reported adverse events were transient and mild-to moderate in severity in both treatment groups, with no serious adverse events reported during the study. Based on the data collected during this study, we conclude that the two presentations of azithromycin were safe and effective in the treatment of impetigo in the population evaluated.

Impétigo herpetiforme recurrente: manejo exitoso con ciclosporina / Recurrent impetigo herpetiformis: Successfully managed with ciclosporine. Report of one case

Impetigo Herpetiformis is a high-risk gestational skin disease that represents a risk for both the mother and offspring. Its management is based on multisystemic support and maternal steroid therapy. When these measures are insufficient to control the disease, the association of ciclosporine to the treatment has been proposed. We report a 24 year-old woman with a 16 weeks pregnancy, that presented with Impetigo Herpetiformis. The disease was refractory to the use of steroids, the patient had a metabolic decompensation and a dehydration with electrolyte imbalance. Therefore, treatment with ciclosporine was initiated and a rapid regression of the lesions was observed. Gestation was maintained, with a good perinatal outcome.

Mupirocin vs terbinafine in impetigo.

OBJECTIVE: Terbinafine is an antifungal drug known to have also antibacterial activity against certain Gram-positive and Gram-negative bacteria. It seems that antibacterial and antifungal activity of terbinafine may have an advantage in the treatment of mixed fungal and bacterial superficial skin infections. Nevertheless, clinical relevance of the antibacterial part of its action has not been investigated efficiently. To compare the efficacy and safety of terbinafine with those of mupirocin, which has already proven antibacterial action, in the treatment of impetigo. METHODS: Children clinically diagnosed as having impetigo were treated with topical mupirocin or topical terbinafine in a randomized fashion. Patients' lesions were examined clinically on days 0, 4, 7, 10 and bacteriologic cultures were obtained on days 0 and 10. RESULTS: A total of 62 patients were included in the study. Forty-eight of these patients were eligible for the efficacy and safety analysis. Twenty-five and 23 patients were treated with mupirocin and terbinafine, respectively. The clinical cure rates were 100% for the mupirocin group and 70% for the terbinafine group (p < 0.05). The bacteriological eradication rate for mupirocin-treated children was 100% and that for terbinafine-treated children was 78% (p < 0.05). Presence of bullous lesions appeared to be a factor for poor clinical outcome in the terbinafine group. Mild local adverse effects were noted in a small percentage of patients in each group. CONCLUSION: Antibacterial activity of terbinafine is not strong enough to be an alternative in the treatment of impertigo. It is advisable that terbinafine could be used in combination with an antibacterial drug for superficial skin infections caused by both fungi and bacteria.

inhibitor of Staphylococcus aureus exfoliative toxin

We describe here an inhibitor of Staphylococcus aureus exfoliative toxin. The toxin was extracted from an S. aureus strain isolated from a case of staphylococcus scalded skin syndrome. The activity of the toxin was compared in tryptic soy broth and brain heart infusion broth. Both supported growth of S. aureus but the culture filtrate of brain heart infusion broth lacked exfoliative toxin activity. Furthermore it appeared to contain a substance that neutralized the action of exfoliative toxin. This suggests the possibility of a treatment for staphylococcal scalded skin syndrome and bullous impetigo

Impetigo:an assessment of etiology and appropriate therapy in infants and children.

We found that mixed organisms of S.aureus and GABHS were the most common cause of impetigo in children in our study; that, of the two regimens evaluated, cloxacillin is the most effective treatment; that penicillin is equally effective in cases of mild to moderate forms and may be preferred on the basis of cost-effectiveness.

Epidermólisis ampollosa distrófica recesiva generalizada (Síndrome de Hallopeau-Siemens): comunicación de un caso / Recessive epidermolysis dystrophic bullous (Hallopeau Siemens Syndrome): a case report

Se reporta el caso de una paciente de 40 días de nacida con un epidermólisis bulosa distrófica recesiva generalizada (Sindrome de Hallopeau-Siemens).

Eficácia e tolerabilidade da miocamicina em duas administraçöes diárias no tratamento de infecçöes pediátricas / Clinical efficacy and tolerance of miocamycin, twice a day, in the management of pediatric infections

Trinta e um pacientes pediátricos, na faixa etária de seis meses a nove anos, com infecçöes de pele e vias aéreas superiores e inferiores, foram tratados com miocamicina na dose de 30 mg/kg/dia, de 12/12 horas, por um período de sete a 14 dias. Em um caso o tratamento estendeu-se por 18 dias. Antes do tratamento, em 28 pacientes colheu-se material das lesöes de pele, das amígdalas ou da secreçäo do ouvido, para realizaçäo de cultura e antibiograma com discos de eritromicina, clindamicina, lincomicina, oxacilina e penicilina, e determinaçäo do MIC para a miocamicina. Foram isolados: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Pseudomonas, Acinetobacter e Morganella morganii. Vinte e nove pacientes ficaram curados. A tolerabilidade foi ótima em 29 casos. Nos dois restantes, um apresentou vômitos, que cederam com antiémetico, e no outro foi necessária a suspensäo do tratamento devido a vômitos e diarréia

Impétigo en niños: etiología y respuesta al tratamiento / Impetigo in children: etiology and response to treatment

Se estudiaron 77 casos de impétigo en niños. Se aisló estreptococo beta hemolítico grupo A como germen único en 25 cultivos, estafilococo aureo en 6 y se obtuvo cultivo mixto en 39. El cultivo fué negativo en 7 casos. La respuesta clínica al tratamiento con penicilina benzatina fué satisfactoria en 93,5% y el 6,5% restante respondió a cloxacilina oral

Estudo comparativo entre o uso tópico de fusidato de sódio a 2%, cloranfenicol, associaçäo neomicina/bacitracina e eritromicina (oral) no tratamento do impetigo estafilocócico do recém-nascido / Comparative study between the topical use of sodium fusiate at 2%, chloramphenicol, combination neomycin/bacitracin and erytromycin (oral) in the treatment of staphylococcal impetigo in newborn infants

Quarenta e oito recém-nascidos portadores de impetigo estafilocócico foram tratados com uso tópico de fusidato de sódio a 2%, cloranfenicol, associaçäo neomicina/bacitracina e eritromicina oral, aleatoriamente, e avaliados no 5§, 7§ e 10§ dia de tratamento, sendo significativa a eficácia do fusidato de sódio a 2% na cura desta infecçäo cutânea